CLVSF News Alert Cellavision Ab (CLVSF) 3.3344 10/01/2014 04

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cellavision Ab (CLVSF) 3.3344 $CLVSF

CellaVision AB: Interim Report January-June 2014
Thomson Reuters ONE - Fri Jul 18, 1:20AM CDT
Continued strong sales growth of 50 percent

CellaVision acquires a new technology platform
Thomson Reuters ONE - Mon Jun 23, 8:01AM CDT
This information was released for public disclosure on June 23, 2014 at 3.00 pm CET.

CellaVision AB: Interim report January - June 2013
Thomson Reuters ONE - Wed Jul 17, 1:31AM CDT
Weak quarter but continued global market initiatives and sales successes in Asia

CellaVision appoints new heads of Quality Assurance and Scientific Affairs
Thomson Reuters ONE - Mon Jun 24, 1:31AM CDT
CellaVision, which develops and sells products for routine analysis of blood and other body fluids in health care services, strengthens its organization with new positions in quality and scientific affairs. Goran Granqvist has been appointed VP Quality, responsible for Quality Assurance and part of the management team. Hans-Inge Bengtsson takes a new role as Director Scientific Affairs.

Sweden's Equalis invests in CellaVision's new product for external quality assurance of laboratory tests in hematology
Thomson Reuters ONE - Tue May 07, 4:02AM CDT
CellaVision has signed an agreement with Equalis, the Swedish provider of external quality assessment for clinical laboratory tests. Equalis has chosen to invest in CellaVision's new proficiency testing program for the identification of cells in blood and other body fluids, CellaVision® Proficiency Software. The order comprises a license for 350 users.

Bulletin from the Annual General Meeting of CellaVision AB (publ) held on April 24, 2013
Thomson Reuters ONE - Wed Apr 24, 12:39PM CDT
CellaVision AB (publ) held its Annual General Meeting today, April 24, 2013, in Lund. The meeting resolved upon the following:

CellaVision AB: Interim report January - March 2013
Thomson Reuters ONE - Wed Apr 24, 7:02AM CDT
More sales channels increase our growth opportunities but the year got off to a weak start

CellaVision and Sysmex announce a jointly-developed product for hematology labs
Thomson Reuters ONE - Tue Apr 16, 8:01AM CDT
This information was released for public disclosure on April 16, 2013 at 3.00 pm CET.

CellaVision and Beckman Coulter enhance partnership by adding EMEA to their global distribution agreement
Thomson Reuters ONE - Mon Apr 08, 1:26AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

CellaVision's 2012 Annual Report now available
Thomson Reuters ONE - Wed Apr 03, 2:01AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

Notice of Annual General Meeting in CellaVision AB, April 24, 2013
Thomson Reuters ONE - Thu Mar 21, 2:31AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

NeuroVive Appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors
PR Newswire - Mon Mar 18, 5:06AM CDT
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company announces that Anna Malm Bernsten and Boel Flodgren have been elected to the Company's Board. Both have exceptional track records and leadership experience and are expected to make a significant contribution to NeuroVive.

CellaVision launches a new product for proficiency testing
Thomson Reuters ONE - Tue Mar 05, 7:01AM CST
CellaVision, which develops and sells products for routine analysis of blood and other body fluids in health care, is launching a new product for internal and external quality assurance and proficiency testing of laboratory analyses. The product, CellaVision® Proficiency Software, targets clinical laboratories that assess and perform the classification of blood cells, as well as accredited providers of external quality assessment schemes for laboratory medicine.

CellaVision adds another distribution agreement for the European market
Thomson Reuters ONE - Mon Feb 25, 5:01AM CST
This information was released for public disclosure on February 25, 2013 at 12.00 am CET.

CellaVision AB: Year-end bulletin 2012
Thomson Reuters ONE - Thu Feb 14, 1:21AM CST
Growth of 9 per cent and strengthened market position




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 120

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 65

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 46

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Austin Rattler Event Revamps With Two-Day Off-Road Bash

Updated Category News Views 42

Austin's Off-Road Bash Kicks Up Dust in Hill Country It's not just another grind in the biking and running world; the Life Time Austin Rattler's gone off the reservation pushing the pedals and the pace across the rugged terrain of Texas Hill Country. Here's to muscles burning and soles slapping the dirt for two straight days, all in the name of challenging nature's best....

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Sandals Foundation: Win a Trip, Boost Caribbean Education

Updated Category News Views 100

Sandals Resorts Stakes a Claim in Education While the rest of us are gravitating towards Black Friday deals and Cyber Monday sales, the Sandals Foundation decided to play a different game. This Giving Tuesday, they invite travelers not just to soak in the sun, but to spread a little of it around by supporting education for kids across the Caribbean. It's a classic example...

Continue Reading
Xiong'an New Area: People's Priorities Reshape Living Spaces

Updated Category News Views 143

Building a City for the People This here is about prioritizing people over skylines. Xiong'an New Area in Hebei Province is shaping up to be more than just a place on the map; it's an experiment in redefining urban living. Skyscrapers and traffic jams? Not on this menu. Instead, nature paves a graceful dance floor between mid-rise residences. Forget your bustling city...

Continue Reading
Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 69

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 139

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 75

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading

Top 5 Most Recently Viewed Articles

Twist Bioscience Set to Showcase Innovations at J.P. Morgan Event

Updated Category News Views 105

Twist Bioscience to Present at Renowned Healthcare Conference Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the synthetic biology and genomics field, has announced an upcoming presentation at the annual J.P. Morgan Healthcare Conference. This significant event is slated for January, and it serves as a vital platform for the company to showcase its...

Continue Reading
Leidos Secures Major NSA Contract Worth $390 Million

Updated Category News Views 154

Leidos Wins $390 Million NSA Signals Intelligence Contract Leidos, a prominent player in the defense and technology sectors, has recently secured a significant contract to enhance the capabilities of the National Security Agency (NSA) in the field of signals intelligence (SIGINT). This contract, valued at $390 million, will span an initial year with four additional...

Continue Reading
Devin Shanahan's Strategic Innovations in Global Trade Adaptation

Updated Category News Views 165

Adapting to Global Trade Challenges In a rapidly changing trade landscape, Devin Shanahan, co-founder of the innovative consumer brand Funtazma, is leading thoughtful changes in supply chain management due to the growing impact of U.S.-China trade tensions. With a wealth of experience in scaling consumer brands through global sourcing, Shanahan has been pivotal in guiding...

Continue Reading
Animal Nutrition Chemicals Market Insights and Growth Prospects

Updated Category News Views 185

Animal Nutrition Chemicals Market Overview The rapidly evolving animal nutrition chemicals market is poised for remarkable growth. As the need for high-quality and nutritious animal feed continues to escalate, this sector is likely to see significant changes and expansion. Comprehensive analyses reveal a bright future as industry players adapt to shifting demands and...

Continue Reading
Investors Ensnared in Orthofix Securities Fraud Case Seek Justice

Updated Category News Views 49

Understanding the Orthofix Securities Fraud Case Recently, investors in Orthofix Medical Inc. were informed about a serious legal action involving alleged securities fraud. The Schall Law Firm, which advocates for shareholder rights, is leading a class action lawsuit that addresses the alleged missteps by Orthofix during a specific time frame. It’s important for...

Continue Reading